Clinical trial
The Effect of Infliximab Therapy in Crohn Patients on Regulatory T-cells
NCT02060318 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Infliximab Therapy in Crohn Patients on Regulatory T-cells
- Lead sponsor
- Hvidovre University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 11, 2014
- Completion date
- March 7, 2016
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.